Markers of oxidative and nitrosative stress in systemic lupus erythematosus: Correlation with disease activity

Arthritis and Rheumatism

Volumn 62, Issue 7, 2010, Pages 2064-2072

  Wang, Gangduo ^a   Pierangeli, Silvia S ^a   Papalardo, Elizabeth ^a   Ansari, G A S ^a   Khan, M Firoze ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME BLOOD LEVEL; FEMALE; HUMAN; IMMUNE RESPONSE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NITROSATIVE STRESS; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MALONDIALDEHYDE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; SEVERITY OF ILLNESS INDEX; SUPEROXIDE DISMUTASE; TYROSINE; YOUNG ADULT;

EID: 77953503390     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27442     Document Type: Article

References (49)

1. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 2006;15:308-18.
2. Kurien BT, Hensley K, Bachmann M, Scofield RH. Oxidatively modified autoantigens in autoimmune diseases. Free Radic Biol Med 2006;41:549-56. (Pubitemid 44080517)
3. Kurien BT, Scofield RH. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 2008;7:567-73.
4. Frostegard J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, et al. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum 2005;52:192-200. (Pubitemid 40129248)
5. Khan MF, Wu X, Ansari GA. Anti-malondialdehyde antibodies in MRL+/+ mice treated with trichloroethene and dichloroacetyl chloride: possible role of lipid peroxidation in autoimmunity. Toxicol Appl Pharmacol 2001;170:88-92. (Pubitemid 32108683)
6. Wang G, Cai P, Ansari GA, Khan MF. Oxidative and nitrosative stress in trichloroethene-mediated autoimmune response. Toxicology 2007;229:186-93. (Pubitemid 44937488)
7. + T cells. Free Radic Biol Med 2008;44:1475-82.
8. Wang G, Wang J, Ma H, Khan MF. Increased nitration and carbonylation of proteins in MRL+/+ mice exposed to trichloroethene: potential role of protein oxidation in autoimmunity. Toxicol Appl Pharmacol 2009;237:188-95.
9. Shacter E. Quantification and significance of protein oxidation in biological samples. Drug Metab Rev 2000;32:307-26. (Pubitemid 32001909)
10. Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA. Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem 2008;283:21837-41.
11. Ozkan Y, Yardym-Akaydyn S, Sepici A, Keskin E, Sepici V, Simsek B. Oxidative status in rheumatoid arthritis. Clin Rheumatol 2007;26:64-8.
12. Grune T, Michel P, Sitte N, Eggert W, Albrecht-Nebe H, Esterbauer H, et al. Increased levels of 4-hydroxynonenal modified proteins in plasma of children with autoimmune diseases. Free Radic Biol Med 1997;23:357-60. (Pubitemid 27276770)
13. Khan MF, Wu X, Ansari GA, Boor PJ. Malondialdehyde-protein adducts in the spleens of aniline-treated rats: immunochemical detection and localization. J Toxicol Environ Health Part A 2003;66:93-102. (Pubitemid 36026873)
14. Kamanli A, Naziroglu M, Aydilek N, Hacievliyagil C. Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct 2004;22:53-7.
15. Januszewski AS, Alderson NL, Jenkins AJ, Thorpe SR, Baynes JW. Chemical modification of proteins during peroxidation of phospholipids. J Lipid Res 2005;46:1440-9.
16. Nuttall SL, Heaton S, Piper MK, Martin U, Gordon C. Cardiovascular risk in systemic lupus erythematosus: evidence of increased oxidative stress and dyslipidaemia. Rheumatology (Oxford) 2003;42:758-62. (Pubitemid 37220907)
17. Matsuura E, Lopez LR. Autoimmune-mediated atherothrombosis. Lupus 2008;17:878-87.
18. Morgan PE, Sturgess AD, Davies MJ. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res 2009;43:117-27.
19. Kurien BT, Scofield RH. Free radical mediated peroxidative damage in systemic lupus erythematosus. Life Sci 2003;73:1655-66.
20. Sampey BP, Korourian S, Ronis MJ, Badger TM, Petersen DR. Immunohistochemical characterization of hepatic malondialdehyde and 4-hydroxynonenal modified proteins during early stages of ethanol-induced liver injury. Alcohol Clin Exp Res 2003;27:1015-22.
21. Ramakrishna V, Jailkhani R. Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol 2008;45:41-6.
22. Weinberg JB, Granger DL, Pisetsky DS, Seldin MF, Misukonis MA, Mason SN, et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 1994;179:651-60.
23. Xia Y, Zweier JL. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A 1997;94:6954-8.
24. Khan MF, Wu X, Kaphalia BS, Boor PJ, Ansari GA. Nitrotyrosine formation in splenic toxicity of aniline. Toxicology 2003;194:95-102.
25. Ohmori H, Kanayama N. Immunogenicity of an inflammation-associated product, tyrosine nitrated self-proteins. Autoimmun Rev 2005;4:224-9.
26. Habib S, Moinuddin, Ali R. Peroxynitrite-modified DNA: a better antigen for systemic lupus erythematosus anti-DNA autoantibodies. Biotechnol Appl Biochem 2006;43(Pt 2):65-70.
27. Karpuzoglu E, Ahmed SA. Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: implications for immunity, autoimmune diseases, and apoptosis. Nitric Oxide 2006;15:177-86. (Pubitemid 44479839)
28. Morgan PE, Sturgess AD, Davies MJ. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum 2005;52:2069-79.
29. Khan F, Siddiqui AA, Ali R. Measurement and significance of 3-nitrotyrosine in systemic lupus erythematosus. Scand J Immunol 2006;64:507-14. (Pubitemid 44536335)
30. Belmont HM, Levartovsky D, Goel A, Amin A, Giorno R, Rediske J, et al. Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:1810-6. (Pubitemid 27452531)
31. Wanchu A, Khullar M, Deodhar SD, Bambery P, Sud A. Nitric oxide synthesis is increased in patients with systemic lupus erythematosus. Rheumatol Int 1998;18:41-3. (Pubitemid 28432832)
32. Nagy G, Clark JM, Buzas EI, Gorman CL, Cope AP. Nitric oxide, chronic inflammation and autoimmunity. Immunol Lett 2007;111:1-5. (Pubitemid 47017476)
33. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
34. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
35. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
36. Khan MF, Wu X, Kaphalia BS, Boor PJ, Ansari GA. Acute hematopoietic toxicity of aniline in rats. Toxicol Lett 1997;92:31-7. (Pubitemid 27289493)
37. Khan MF, Wu X, Tipnis UR, Ansari GA, Boor PJ. Protein adducts of malondialdehyde and 4-hydroxynonenal in livers of iron loaded rats: quantitation and localization. Toxicology 2002;173:193-201. (Pubitemid 34311855)
38. Wang G, Ansari GA, Khan MF. Involvement of lipid peroxidation-derived aldehyde-protein adducts in autoimmunity mediated by trichloroethene. J Toxicol Environ Health A 2007;70:1977-85.
39. Uchida K, Szweda LI, Chae HZ, Stadtman ER. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl Acad Sci U S A 1993;90:8742-6. (Pubitemid 23277746)
40. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991;11:81-128. (Pubitemid 121003917)
41. Tuma DJ. Role of malondialdehyde-acetaldehyde adducts in liver injury. Free Radic Biol Med 2002;32:303-8.
42. Devaraj S, Leonard S, Traber MG, Jialal I. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med 2008;44:1203-8.
43. Fenaille F, Tabet JC, Guy PA. Identification of 4-hydroxy-2-nonenal- modified peptides within unfractionated digests using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Chem 2004;76:867-73. (Pubitemid 38235532)
44. Toyoda K, Nagae R, Akagawa M, Ishino K, Shibata T, Ito S, et al. Protein-bound 4-hydroxy-2-nonenal: an endogenous triggering antigen of anti-DNA response. J Biol Chem 2007;282:25769-78.
45. Iborra A, Palacio JR, Martinez P. Oxidative stress and autoimmune response in the infertile woman. Chem Immunol Allergy 2005;88:150-62. (Pubitemid 43094383)
46. Khan F, Ali R. Antibodies against nitric oxide damaged poly L-tyrosine and 3-nitrotyrosine levels in systemic lupus erythematosus. J Biochem Mol Biol 2006;39:189-96.
47. Nemirovskiy OV, Radabaugh MR, Aggarwal P, Funckes-Shippy CL, Mnich SJ, Meyer DM, et al. Plasma 3-nitrotyrosine is a biomarker in animal models of arthritis: pharmacological dissection of iNOS' role in disease. Nitric Oxide 2009;20:150-6.
48. Djordjevic VB, Stankovic T, Cosic V, Zvezdanovic L, Kamenov B, Tasic-Dimov D, et al. Immune system-mediated endothelial damage is associated with NO and antioxidant system disorders. Clin Chem Lab Med 2004;42:1117-21. (Pubitemid 39481151)
49. Cuzzocrea S. Role of nitric oxide and reactive oxygen species in arthritis. Curr Pharm Des 2006;12:3551-70. (Pubitemid 44400492)